Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck

Showing 15 posts of 363 posts found.

Merck drug shines at ASCO

June 4, 2014
Research and Development, Sales and Marketing ASCO, Cancer, FDA, MK-3475, Merck, melanoma

Merck has shown off one of its investigative cancer drug’s impressive results in advanced head and neck cancer at ASCO …

News
Bruno image

Novartis hires Merck president to lead oncology

June 3, 2014
Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology

Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology.  The role was …

News
BMS image

BMS signs cancer deal

May 28, 2014
Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

News

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014
Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

News

Merck sells Colorado biologics plant to KBI

May 18, 2014
Manufacturing and Production KBI, Merck, manufacturing

Merck & Co has swung the axe over its M&P operations again – this time for its biologics plant in …

News

ASCO 2014: Cancer immune therapy race heats up

May 15, 2014
2014, ASCO, AZ, BMS, Cancer, Merck, Roche, chicago

A number of major players in oncology are set to showcase rival immunotherapy data at this year’s American Society of …

News
Merck image

Merck’s vorapaxar gains long-awaited FDA approval

May 9, 2014
Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …

News

Bayer concludes $14bn Merck consumer care takeover

May 7, 2014
Sales and Marketing Bayer, Merck, OTC, consumer care, merger

 Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …

News
Bayer image

Bayer to make $14 bn move for Merck unit

May 2, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Merck, Novartis, Reckitt Benckiser, claritin, reuters

Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …

News
Merck image

Merck’s Q1 sales drop

April 30, 2014
Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales

Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …

News
merck_incweb

Merck gets hep C boost as competition ramps up

April 11, 2014
Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi

Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …

News

Major new launches for 2014

March 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10

 AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

Feature
GSK image

GSK tops drug approval rates

March 7, 2014
Medical Communications, Sales and Marketing FDA, GSK, J&J, JJ, Merck, Sanofi, ep, evaluate pharma, lilly, nme

GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …

News
merck image

Merck in $100 million contraceptive settlement

February 10, 2014
Sales and Marketing Merck, birth, birth control, legal, nuvaring

Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …

News
Merck image

Merck: ‘2014 revenues will be down’

February 7, 2014
Sales and Marketing Frazier, Merck, Simponi, Singulair, isentress, q4, results

Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026